Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

MOTRIN MIGRAINE PAIN

IBUPROFEN

Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Label for Motrin IB Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview MOTRIN MIGRAINE PAIN is listed in Drugs@FDA under application 019012 (NDA).

Label for Motrin IB Review priority: STANDARD Marketing status: Discontinued Active ingredient IBUPROFEN Form and strength TABLET;ORAL - 200MG Sponsor KENVUE BRANDS Submission history Latest submission status date: 2021-11-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview MOTRIN MIGRAINE PAIN is listed in Drugs@FDA under application 019012 (NDA). Label for Motrin IB Review priority: STANDARD Marketing status: Discontinued Active ingredient IBUPROFEN Form and strength TABLET;ORAL - 200MG Sponsor KENVUE BRANDS Submission history Latest submission status date: 2021-11-16 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
MOTRIN MIGRAINE PAIN (IBUPROFEN) | Drug Monograph | MedicHelpline